Related Experiment Videos
[Transfer of multiple sclerosis into SCID mice]
S Sakoda1, Y Nakatsuji, H Fujimura
1Osaka University Medical School, Department of Neurology.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|November 1, 1994
Summary
This study shows that blocking TNF-alpha and targeting T cells can prevent the transfer of multiple sclerosis (MS) in mice. These findings suggest potential new treatments for MS by controlling these factors.
Area of Science:
- Neuroimmunology
- Experimental Neurology
Context:
- Multiple Sclerosis (MS) pathogenesis remains incompletely understood.
- Previous studies successfully transferred MS to SCID mice using cerebrospinal fluid (CSF) cells.
- Elevated cytokine mRNA (TNF-alpha, IL-6) was observed in SCID-hu-MS lesions.
Purpose:
- To investigate the role of TNF-alpha and T cells in MS transfer to SCID mice.
- To test the efficacy of antibodies against TNF-alpha and CD3 in preventing MS transfer.
Summary:
- Intracisternal injection of CSF cells from MS patients into SCID mice successfully transferred the disease.
- Administration of an antibody to murine TNF-alpha effectively prevented MS transfer.
- An antibody to human CD3 (OKT3) also demonstrated a preventive effect, indicating T cell involvement.
Impact:
- Findings suggest that targeting TNF-alpha could be a viable therapeutic strategy for MS.
- The study provides evidence supporting MS as a T cell-mediated autoimmune disease.
- This research advances the understanding of MS pathophysiology in an experimental model.